BOSTON, MA, Sherlock Biosciences, a company engineering biology, has raised $80 million in a Series B financing led by Novalis LifeSciences.
Sherlock Biosciences Scores $80M in Series B
BOSTON, MA, Sherlock Biosciences, a company engineering biology, has raised $80 million in a Series B financing led by Novalis LifeSciences.
